As shown in Table 1 , the correlation between high CDKN3 expression levels and poor patient survival were consistently observed in majority of the subgroups in all three datasets, including all the age and gender groups, the MYCN-nonamplified groups and the stages 2 - 4 groups, although some of the correlations did not reach statistical significance.
← all excerpts
Identification of CDKN3 as a Key Gene that Regulates Neuroblastoma Cell Differentiation.
1
—
—